Rapamycin boosts cardiac and skeletal muscle function

July 25, 2012

Rapamycin, a drug used in transplant patients to prevent organ rejection, may reverse cardiac and skeletal muscle defects as well, a new mouse study published today in Science Translational Medicine suggests.


CTRC director takes to medical journals to debate PSA testing

July 20, 2012

Debate continues to swirl in the medical community over when to recommend PSA testing to look for prostate cancer in men, and Ian M. Thompson Jr., M.D., director of the Cancer Therapy & Research Center at the UT Health Science Center, is weighing in twice this week in major medical journals.